Search
for
Sort by
Research 30 of 1000+
- Simultaneous spectrophotometric determination of finasteride and tadalafil in recently FDA approved Entadfi™ capsules
- Tissue Expansion in the Head and Neck
- Predstanormix Duo – a new domestic combination drug for the treatment of lower urinary tract dysfunction symptoms associated with BPH.
- The beneficial effects of Pumpkin (<i>Cucurbita pepo</i>L.) seed oil for health condition of men
- Nanoporous Silica Entrapped Lipid-Drug Complexes for the Solubilization and Absorption Enhancement of Poorly Soluble Drugs
- The endoscopic surgical monitoring system-guided impact factors exploring of blood loss and fluid absorption during plasmakinetic TURP: a prospective study in high-risk BPH patients
- Evaluation of Polymorphism Influence in the Finasteride
- A Dissolution Test for Finasteride in Immediate-Release Capsules
- Comparison of Intraoperative Blood Loss in Patients With Benign Prostatic Hyperplasia Undergoing Bipolar Transurethral Resection of the Prostate With and Without Preoperative Oral Finasteride
- What do we know about phytotherapy of benign prostatic hyperplasia?
- Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride
- Effect of Citrullus colocynthis Schard on Testosterone-Induced Benign Prostatic Hyperplasia
- Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model
- Effect of the ethanol extract of Syzygium aromaticum (clove) leaves on the lipid profile and body weight in testosterone-induced benign prostatic hyperplasia rats
- Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteers
- The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- DEVELOPING AND VALIDATING AN HPLC METHOD TO QUANTIFY SIMULTANEOUSLY DUTASTERIDE AND THEIR RELATED MOLECULES (DUTASTERIDE ACID, 2,5 BIS- (TRI FLUORO METHYL)-ANILINE AND DUTASTERIDE 17 α-EPIMER) IN CAPSULES
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Finasteride, A Steroid 5α-Reductase Inhibitor, Does Not Affect the Oxidative Metabolism of Antipyrine
- Complications of cataract surgery in Wistar rats undergoing treatment with tamsulosin
- Dutasteride: a guide to its use as monotherapy in benign prostatic hyperplasia
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Herbs for Benign Prostatic Hyperplasia
- The placebo effect and randomized trials: analysis of conventional medicine
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- Clinical use of 5α-reductase inhibitors
- Dutasteride: A Review of its Use in the Management of Prostate Disorders